Fig. 9From: Identification and validation of IRF6 related to ovarian cancer and biological function and prognostic valueDrug sensitivity analysis. The expression of IRF6 was associated with the sensitivity of Cisplatin,Carboplatin,IDH-C227,P-529,Gemcitabine, SR16157, SGI-1027,Voreloxin, Bisacodyl acvtive i,Linsitinib, Bleomycin, LOXO-101,Uracil mustard, BAY-876,Momelotinib,By-product of CUDC-305.Downloaded from CellMiner were the molecular and pharmacological characteristics of NCI-60 cancer cellsBack to article page